News

Find News

Filter articles

Showing 3071 to 3080 of 3112 results

Monsanto v Bowman: Supreme Court rejects “blame-the-bean” defence

US14-05-2013

The US Supreme Court has decided unanimously in favour of agricultural company Monsanto in its patent battle against Indiana farmer Vernon Bowman.

AstraZeneca loses Seroquel appeal

UK10-05-2013

The UK Court of Appeal has upheld the High Court’s decision that AstraZeneca’s patent for a sustained release formulation of anti-psychotic drug quetiapine is invalid.

Pfizer sells Viagra online to curb counterfeit trade

US09-05-2013

Pfizer has announced it will sell its erectile dysfunction pill Viagra online in an effort to counter the rising threat of bogus online pharmacies.

Acura sues Ranbaxy over abuse-resistant generic

US01-05-2013

Acura Pharmaceuticals has sued Ranbaxy Laboratories to keep it from releasing a generic version of its immediate release tablet formulation of painkiller Oxecta.

Cyclacel sells cancer drug patents to Celgene

US30-04-2013Legal developments

Cyclacel Pharmaceuticals has entered into a definitive agreement to sell four of its patents related to the use of the romidepsin injection to Celgene Corporation.

Baker & McKenzie Mexico hires life sciences head

Mexico30-04-2013

Baker & McKenzie has hired Christian Alejandro López-Silva as head of its pharmaceutical and life sciences group in Mexico.

Actavis eyes $100 million after OxyContin settlement

US29-04-2013

Generic drug-maker Actavis believes it will earn profits of around $100 million in the next two years from licensing patents owned by Purdue Pharma LP.

Orchid invests in new European pharma

France, Germany, India25-04-2013

Indian pharmaceutical company Orchid Chemicals and Pharmaceuticals has entered into a partnership with new European biopharmaceutical company Allecra Therapeutics.

FTC critical of pay-for-delay in annual report

US24-04-2013

The US Federal Trade Commission has published its annual report for 2012, in which it remains critical of “pay-for-delay” patent settlements.

Shionogi sues Hospira to block Doribax generic

US19-04-2013

Japanese pharma Shionogi has brought a lawsuit against Hospira Inc to keep it from marketing a generic version of Shionogi’s Doribax, alleging it infringes one of the company’s patents.

Showing 3071 to 3080 of 3112 results

LSIPR